nodes	percent_of_prediction	percent_of_DWPC	metapath
Valrubicin—TOP2A—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.0147	0.724	CbGdCrCtD
Valrubicin—Doxorubicin—NOS1—type 2 diabetes mellitus	0.0088	0.288	CrCbGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—S100A6—type 2 diabetes mellitus	0.00701	0.171	CbGpPWpGaD
Valrubicin—TOP2A—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00559	0.276	CbGdCrCtD
Valrubicin—Doxorubicin—NOS3—type 2 diabetes mellitus	0.00479	0.156	CrCbGaD
Valrubicin—Doxorubicin—NOS2—type 2 diabetes mellitus	0.00462	0.151	CrCbGaD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—FAF1—type 2 diabetes mellitus	0.00405	0.0987	CbGpPWpGaD
Valrubicin—Daunorubicin—ABCC2—type 2 diabetes mellitus	0.00378	0.123	CrCbGaD
Valrubicin—Doxorubicin—ABCC2—type 2 diabetes mellitus	0.00307	0.1	CrCbGaD
Valrubicin—Rash—Linagliptin—type 2 diabetes mellitus	0.00283	0.00312	CcSEcCtD
Valrubicin—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00283	0.00311	CcSEcCtD
Valrubicin—Headache—Linagliptin—type 2 diabetes mellitus	0.00281	0.0031	CcSEcCtD
Valrubicin—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00278	0.00306	CcSEcCtD
Valrubicin—Vomiting—Acarbose—type 2 diabetes mellitus	0.00277	0.00305	CcSEcCtD
Valrubicin—Rash—Acarbose—type 2 diabetes mellitus	0.00275	0.00302	CcSEcCtD
Valrubicin—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00274	0.00302	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Glipizide—type 2 diabetes mellitus	0.00274	0.00302	CcSEcCtD
Valrubicin—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00269	0.00297	CcSEcCtD
Valrubicin—Nausea—Tolazamide—type 2 diabetes mellitus	0.00269	0.00297	CcSEcCtD
Valrubicin—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00267	0.00294	CcSEcCtD
Valrubicin—Rash—Nateglinide—type 2 diabetes mellitus	0.00265	0.00292	CcSEcCtD
Valrubicin—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00265	0.00291	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.00263	0.00289	CcSEcCtD
Valrubicin—Anaemia—Glyburide—type 2 diabetes mellitus	0.00262	0.00289	CcSEcCtD
Valrubicin—Oedema peripheral—Orlistat—type 2 diabetes mellitus	0.00262	0.00288	CcSEcCtD
Valrubicin—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.0026	0.00287	CcSEcCtD
Valrubicin—Pneumonia—Irbesartan—type 2 diabetes mellitus	0.00259	0.00285	CcSEcCtD
Valrubicin—Nausea—Acarbose—type 2 diabetes mellitus	0.00259	0.00285	CcSEcCtD
Valrubicin—Pruritus—Repaglinide—type 2 diabetes mellitus	0.00257	0.00283	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.00255	0.00281	CcSEcCtD
Valrubicin—Daunorubicin—CYP1A2—type 2 diabetes mellitus	0.00252	0.0824	CrCbGaD
Valrubicin—Flatulence—Gliclazide—type 2 diabetes mellitus	0.00251	0.00276	CcSEcCtD
Valrubicin—Pollakiuria—Losartan—type 2 diabetes mellitus	0.00251	0.00276	CcSEcCtD
Valrubicin—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.0025	0.00275	CcSEcCtD
Valrubicin—Nausea—Nateglinide—type 2 diabetes mellitus	0.00249	0.00275	CcSEcCtD
Valrubicin—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.00249	0.00274	CcSEcCtD
Valrubicin—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00248	0.00273	CcSEcCtD
Valrubicin—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00247	0.00271	CcSEcCtD
Valrubicin—Back pain—Gliclazide—type 2 diabetes mellitus	0.00246	0.00271	CcSEcCtD
Valrubicin—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.00246	0.00271	CcSEcCtD
Valrubicin—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.00245	0.0027	CcSEcCtD
Valrubicin—Pneumonia—Losartan—type 2 diabetes mellitus	0.00244	0.00268	CcSEcCtD
Valrubicin—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.00243	0.00268	CcSEcCtD
Valrubicin—Myalgia—Glyburide—type 2 diabetes mellitus	0.00241	0.00266	CcSEcCtD
Valrubicin—Oedema peripheral—Metformin—type 2 diabetes mellitus	0.00241	0.00266	CcSEcCtD
Valrubicin—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00238	0.00262	CcSEcCtD
Valrubicin—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00237	0.00261	CcSEcCtD
Valrubicin—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.00236	0.0026	CcSEcCtD
Valrubicin—Anaemia—Gliclazide—type 2 diabetes mellitus	0.00235	0.00259	CcSEcCtD
Valrubicin—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.00235	0.00259	CcSEcCtD
Valrubicin—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00235	0.00259	CcSEcCtD
Valrubicin—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00231	0.00255	CcSEcCtD
Valrubicin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00231	0.00255	CcSEcCtD
Valrubicin—Flatulence—Valsartan—type 2 diabetes mellitus	0.00231	0.00254	CcSEcCtD
Valrubicin—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00231	0.00254	CcSEcCtD
Valrubicin—Malaise—Gliclazide—type 2 diabetes mellitus	0.0023	0.00253	CcSEcCtD
Valrubicin—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.0023	0.00253	CcSEcCtD
Valrubicin—Rash—Repaglinide—type 2 diabetes mellitus	0.00229	0.00252	CcSEcCtD
Valrubicin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00229	0.00252	CcSEcCtD
Valrubicin—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00229	0.00252	CcSEcCtD
Valrubicin—Flatulence—Orlistat—type 2 diabetes mellitus	0.00228	0.00251	CcSEcCtD
Valrubicin—Headache—Repaglinide—type 2 diabetes mellitus	0.00228	0.00251	CcSEcCtD
Valrubicin—Oedema peripheral—Irbesartan—type 2 diabetes mellitus	0.00228	0.00251	CcSEcCtD
Valrubicin—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00227	0.0025	CcSEcCtD
Valrubicin—Back pain—Valsartan—type 2 diabetes mellitus	0.00226	0.00249	CcSEcCtD
Valrubicin—Back pain—Orlistat—type 2 diabetes mellitus	0.00224	0.00246	CcSEcCtD
Valrubicin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00222	0.00244	CcSEcCtD
Valrubicin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00221	0.00244	CcSEcCtD
Valrubicin—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00217	0.00239	CcSEcCtD
Valrubicin—Myalgia—Gliclazide—type 2 diabetes mellitus	0.00217	0.00239	CcSEcCtD
Valrubicin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00217	0.00239	CcSEcCtD
Valrubicin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00216	0.00238	CcSEcCtD
Valrubicin—Nausea—Repaglinide—type 2 diabetes mellitus	0.00216	0.00238	CcSEcCtD
Valrubicin—Asthenia—Glipizide—type 2 diabetes mellitus	0.00216	0.00238	CcSEcCtD
Valrubicin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00215	0.00237	CcSEcCtD
Valrubicin—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.00215	0.00236	CcSEcCtD
Valrubicin—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00214	0.00236	CcSEcCtD
Valrubicin—Pruritus—Glipizide—type 2 diabetes mellitus	0.00213	0.00234	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.00211	0.00232	CcSEcCtD
Valrubicin—Flatulence—Metformin—type 2 diabetes mellitus	0.0021	0.00231	CcSEcCtD
Valrubicin—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00209	0.0023	CcSEcCtD
Valrubicin—Malaise—Orlistat—type 2 diabetes mellitus	0.00209	0.0023	CcSEcCtD
Valrubicin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00207	0.00228	CcSEcCtD
Valrubicin—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00207	0.00228	CcSEcCtD
Valrubicin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00206	0.00227	CcSEcCtD
Valrubicin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00204	0.00225	CcSEcCtD
Valrubicin—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.00202	0.00222	CcSEcCtD
Valrubicin—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00201	0.00222	CcSEcCtD
Valrubicin—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00201	0.00221	CcSEcCtD
Valrubicin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.002	0.0022	CcSEcCtD
Valrubicin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.002	0.0022	CcSEcCtD
Valrubicin—Chest pain—Valsartan—type 2 diabetes mellitus	0.00199	0.00219	CcSEcCtD
Valrubicin—Myalgia—Valsartan—type 2 diabetes mellitus	0.00199	0.00219	CcSEcCtD
Valrubicin—Dizziness—Glipizide—type 2 diabetes mellitus	0.00199	0.00219	CcSEcCtD
Valrubicin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00199	0.00219	CcSEcCtD
Valrubicin—Flatulence—Irbesartan—type 2 diabetes mellitus	0.00198	0.00218	CcSEcCtD
Valrubicin—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00198	0.00218	CcSEcCtD
Valrubicin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00197	0.00217	CcSEcCtD
Valrubicin—Myalgia—Orlistat—type 2 diabetes mellitus	0.00197	0.00217	CcSEcCtD
Valrubicin—Chest pain—Orlistat—type 2 diabetes mellitus	0.00197	0.00217	CcSEcCtD
Valrubicin—Discomfort—Orlistat—type 2 diabetes mellitus	0.00194	0.00214	CcSEcCtD
Valrubicin—Malaise—Metformin—type 2 diabetes mellitus	0.00192	0.00212	CcSEcCtD
Valrubicin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00192	0.00211	CcSEcCtD
Valrubicin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00191	0.00211	CcSEcCtD
Valrubicin—Vomiting—Glipizide—type 2 diabetes mellitus	0.00191	0.00211	CcSEcCtD
Valrubicin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00191	0.0021	CcSEcCtD
Valrubicin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00191	0.0021	CcSEcCtD
Valrubicin—Rash—Glipizide—type 2 diabetes mellitus	0.0019	0.00209	CcSEcCtD
Valrubicin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00189	0.00209	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00189	0.00209	CcSEcCtD
Valrubicin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00189	0.00208	CcSEcCtD
Valrubicin—Headache—Glipizide—type 2 diabetes mellitus	0.00188	0.00207	CcSEcCtD
Valrubicin—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.00187	0.00205	CcSEcCtD
Valrubicin—Flatulence—Losartan—type 2 diabetes mellitus	0.00186	0.00205	CcSEcCtD
Valrubicin—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00186	0.00205	CcSEcCtD
Valrubicin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00186	0.00204	CcSEcCtD
Valrubicin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00185	0.00204	CcSEcCtD
Valrubicin—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.00184	0.00202	CcSEcCtD
Valrubicin—Back pain—Losartan—type 2 diabetes mellitus	0.00183	0.00202	CcSEcCtD
Valrubicin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00183	0.00202	CcSEcCtD
Valrubicin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00182	0.002	CcSEcCtD
Valrubicin—Chest pain—Metformin—type 2 diabetes mellitus	0.00181	0.002	CcSEcCtD
Valrubicin—Myalgia—Metformin—type 2 diabetes mellitus	0.00181	0.002	CcSEcCtD
Valrubicin—Malaise—Irbesartan—type 2 diabetes mellitus	0.00181	0.002	CcSEcCtD
Valrubicin—Headache—Pioglitazone—type 2 diabetes mellitus	0.00181	0.00199	CcSEcCtD
Valrubicin—Discomfort—Metformin—type 2 diabetes mellitus	0.00179	0.00197	CcSEcCtD
Valrubicin—Nausea—Glipizide—type 2 diabetes mellitus	0.00179	0.00197	CcSEcCtD
Valrubicin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00178	0.00197	CcSEcCtD
Valrubicin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00178	0.00196	CcSEcCtD
Valrubicin—Rash—Glimepiride—type 2 diabetes mellitus	0.00177	0.00195	CcSEcCtD
Valrubicin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00177	0.00195	CcSEcCtD
Valrubicin—Rash—Sitagliptin—type 2 diabetes mellitus	0.00176	0.00194	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—CARTPT—type 2 diabetes mellitus	0.00176	0.043	CbGpPWpGaD
Valrubicin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00176	0.00194	CcSEcCtD
Valrubicin—Headache—Glimepiride—type 2 diabetes mellitus	0.00176	0.00194	CcSEcCtD
Valrubicin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.00176	0.00193	CcSEcCtD
Valrubicin—Headache—Sitagliptin—type 2 diabetes mellitus	0.00175	0.00193	CcSEcCtD
Valrubicin—Anaemia—Losartan—type 2 diabetes mellitus	0.00175	0.00193	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00174	0.00192	CcSEcCtD
Valrubicin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00173	0.00191	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00172	0.00189	CcSEcCtD
Valrubicin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00171	0.00189	CcSEcCtD
Valrubicin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00171	0.00189	CcSEcCtD
Valrubicin—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00171	0.00189	CcSEcCtD
Valrubicin—Malaise—Losartan—type 2 diabetes mellitus	0.00171	0.00188	CcSEcCtD
Valrubicin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.0017	0.00187	CcSEcCtD
Valrubicin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00169	0.00186	CcSEcCtD
Valrubicin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00167	0.00184	CcSEcCtD
Valrubicin—Daunorubicin—CYP3A4—type 2 diabetes mellitus	0.00167	0.0546	CrCbGaD
Valrubicin—Nausea—Glimepiride—type 2 diabetes mellitus	0.00167	0.00184	CcSEcCtD
Valrubicin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00166	0.00183	CcSEcCtD
Valrubicin—Asthenia—Glyburide—type 2 diabetes mellitus	0.00166	0.00183	CcSEcCtD
Valrubicin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00164	0.00181	CcSEcCtD
Valrubicin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00164	0.00181	CcSEcCtD
Valrubicin—Pruritus—Glyburide—type 2 diabetes mellitus	0.00164	0.0018	CcSEcCtD
Valrubicin—Myalgia—Losartan—type 2 diabetes mellitus	0.00161	0.00177	CcSEcCtD
Valrubicin—Chest pain—Losartan—type 2 diabetes mellitus	0.00161	0.00177	CcSEcCtD
Valrubicin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00161	0.00177	CcSEcCtD
Valrubicin—Rash—Bromocriptine—type 2 diabetes mellitus	0.0016	0.00176	CcSEcCtD
Valrubicin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.0016	0.00176	CcSEcCtD
Valrubicin—Discomfort—Losartan—type 2 diabetes mellitus	0.00159	0.00175	CcSEcCtD
Valrubicin—Headache—Bromocriptine—type 2 diabetes mellitus	0.00159	0.00175	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00158	0.00174	CcSEcCtD
Valrubicin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00158	0.00174	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—PROX1—type 2 diabetes mellitus	0.00157	0.0383	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—AGRP—type 2 diabetes mellitus	0.00157	0.0383	CbGpPWpGaD
Valrubicin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00156	0.00172	CcSEcCtD
Valrubicin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00155	0.00171	CcSEcCtD
Valrubicin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00154	0.0017	CcSEcCtD
Valrubicin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00151	0.00166	CcSEcCtD
Valrubicin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00151	0.00166	CcSEcCtD
Valrubicin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.0015	0.00166	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.0015	0.00165	CcSEcCtD
Valrubicin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00149	0.00164	CcSEcCtD
Valrubicin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00149	0.00164	CcSEcCtD
Valrubicin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00149	0.00164	CcSEcCtD
Valrubicin—Vomiting—Glyburide—type 2 diabetes mellitus	0.00147	0.00162	CcSEcCtD
Valrubicin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00147	0.00162	CcSEcCtD
Valrubicin—Malaise—Ramipril—type 2 diabetes mellitus	0.00146	0.00161	CcSEcCtD
Valrubicin—Rash—Glyburide—type 2 diabetes mellitus	0.00146	0.00161	CcSEcCtD
Valrubicin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00146	0.00161	CcSEcCtD
Valrubicin—Headache—Glyburide—type 2 diabetes mellitus	0.00145	0.0016	CcSEcCtD
Valrubicin—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00143	0.00158	CcSEcCtD
Valrubicin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00142	0.00157	CcSEcCtD
Valrubicin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00142	0.00157	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00141	0.00155	CcSEcCtD
Valrubicin—Chest pain—Ramipril—type 2 diabetes mellitus	0.00138	0.00152	CcSEcCtD
Valrubicin—Myalgia—Ramipril—type 2 diabetes mellitus	0.00138	0.00152	CcSEcCtD
Valrubicin—Nausea—Glyburide—type 2 diabetes mellitus	0.00137	0.00151	CcSEcCtD
Valrubicin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00137	0.00151	CcSEcCtD
Valrubicin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00137	0.00151	CcSEcCtD
Valrubicin—Asthenia—Valsartan—type 2 diabetes mellitus	0.00137	0.00151	CcSEcCtD
Valrubicin—Discomfort—Ramipril—type 2 diabetes mellitus	0.00136	0.0015	CcSEcCtD
Valrubicin—Doxorubicin—CYP3A4—type 2 diabetes mellitus	0.00135	0.0443	CrCbGaD
Valrubicin—Asthenia—Orlistat—type 2 diabetes mellitus	0.00135	0.00149	CcSEcCtD
Valrubicin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00135	0.00149	CcSEcCtD
Valrubicin—Pruritus—Valsartan—type 2 diabetes mellitus	0.00135	0.00149	CcSEcCtD
Valrubicin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00134	0.00148	CcSEcCtD
Valrubicin—Pruritus—Orlistat—type 2 diabetes mellitus	0.00134	0.00147	CcSEcCtD
Valrubicin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00132	0.00146	CcSEcCtD
Valrubicin—Rash—Gliclazide—type 2 diabetes mellitus	0.00131	0.00144	CcSEcCtD
Valrubicin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00131	0.00144	CcSEcCtD
Valrubicin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00131	0.00144	CcSEcCtD
Valrubicin—Headache—Gliclazide—type 2 diabetes mellitus	0.0013	0.00143	CcSEcCtD
Valrubicin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.0013	0.00143	CcSEcCtD
Valrubicin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.0013	0.00143	CcSEcCtD
Valrubicin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00129	0.00142	CcSEcCtD
Valrubicin—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00127	0.0014	CcSEcCtD
Valrubicin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00126	0.00139	CcSEcCtD
Valrubicin—Dizziness—Valsartan—type 2 diabetes mellitus	0.00126	0.00139	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—PTGDS—type 2 diabetes mellitus	0.00126	0.0306	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—AANAT—type 2 diabetes mellitus	0.00126	0.0306	CbGpPWpGaD
Valrubicin—Dizziness—Orlistat—type 2 diabetes mellitus	0.00125	0.00137	CcSEcCtD
Valrubicin—Asthenia—Metformin—type 2 diabetes mellitus	0.00125	0.00137	CcSEcCtD
Valrubicin—Nausea—Gliclazide—type 2 diabetes mellitus	0.00123	0.00136	CcSEcCtD
Valrubicin—Pruritus—Metformin—type 2 diabetes mellitus	0.00123	0.00135	CcSEcCtD
Valrubicin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00122	0.00134	CcSEcCtD
Valrubicin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00122	0.00134	CcSEcCtD
Valrubicin—Vomiting—Valsartan—type 2 diabetes mellitus	0.00121	0.00134	CcSEcCtD
Valrubicin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.00121	0.00133	CcSEcCtD
Valrubicin—Rash—Valsartan—type 2 diabetes mellitus	0.0012	0.00133	CcSEcCtD
Valrubicin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.0012	0.00132	CcSEcCtD
Valrubicin—Vomiting—Orlistat—type 2 diabetes mellitus	0.0012	0.00132	CcSEcCtD
Valrubicin—Headache—Valsartan—type 2 diabetes mellitus	0.0012	0.00132	CcSEcCtD
Valrubicin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00119	0.00131	CcSEcCtD
Valrubicin—Rash—Orlistat—type 2 diabetes mellitus	0.00119	0.00131	CcSEcCtD
Valrubicin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00119	0.00131	CcSEcCtD
Valrubicin—Headache—Orlistat—type 2 diabetes mellitus	0.00118	0.0013	CcSEcCtD
Valrubicin—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00118	0.0013	CcSEcCtD
Valrubicin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00116	0.00128	CcSEcCtD
Valrubicin—Dizziness—Metformin—type 2 diabetes mellitus	0.00115	0.00127	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—MTNR1A—type 2 diabetes mellitus	0.00114	0.0277	CbGpPWpGaD
Valrubicin—Nausea—Valsartan—type 2 diabetes mellitus	0.00113	0.00125	CcSEcCtD
Valrubicin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00112	0.00124	CcSEcCtD
Valrubicin—Nausea—Orlistat—type 2 diabetes mellitus	0.00112	0.00123	CcSEcCtD
Valrubicin—Asthenia—Losartan—type 2 diabetes mellitus	0.00111	0.00122	CcSEcCtD
Valrubicin—Vomiting—Metformin—type 2 diabetes mellitus	0.00111	0.00122	CcSEcCtD
Valrubicin—Rash—Metformin—type 2 diabetes mellitus	0.0011	0.00121	CcSEcCtD
Valrubicin—Dermatitis—Metformin—type 2 diabetes mellitus	0.0011	0.00121	CcSEcCtD
Valrubicin—Pruritus—Losartan—type 2 diabetes mellitus	0.00109	0.0012	CcSEcCtD
Valrubicin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00109	0.0012	CcSEcCtD
Valrubicin—Headache—Metformin—type 2 diabetes mellitus	0.00109	0.0012	CcSEcCtD
Valrubicin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00109	0.0012	CcSEcCtD
Valrubicin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.00108	0.00119	CcSEcCtD
Valrubicin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00106	0.00116	CcSEcCtD
Valrubicin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00105	0.00115	CcSEcCtD
Valrubicin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00105	0.00115	CcSEcCtD
Valrubicin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00104	0.00115	CcSEcCtD
Valrubicin—Rash—Irbesartan—type 2 diabetes mellitus	0.00103	0.00114	CcSEcCtD
Valrubicin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00103	0.00114	CcSEcCtD
Valrubicin—Nausea—Metformin—type 2 diabetes mellitus	0.00103	0.00114	CcSEcCtD
Valrubicin—Headache—Irbesartan—type 2 diabetes mellitus	0.00103	0.00113	CcSEcCtD
Valrubicin—Dizziness—Losartan—type 2 diabetes mellitus	0.00102	0.00112	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—PAX4—type 2 diabetes mellitus	0.00101	0.0247	CbGpPWpGaD
Valrubicin—Vomiting—Losartan—type 2 diabetes mellitus	0.000982	0.00108	CcSEcCtD
Valrubicin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000975	0.00107	CcSEcCtD
Valrubicin—Rash—Losartan—type 2 diabetes mellitus	0.000974	0.00107	CcSEcCtD
Valrubicin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000973	0.00107	CcSEcCtD
Valrubicin—Headache—Losartan—type 2 diabetes mellitus	0.000968	0.00107	CcSEcCtD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PLN—type 2 diabetes mellitus	0.000965	0.0235	CbGpPWpGaD
Valrubicin—Asthenia—Ramipril—type 2 diabetes mellitus	0.00095	0.00105	CcSEcCtD
Valrubicin—Pruritus—Ramipril—type 2 diabetes mellitus	0.000937	0.00103	CcSEcCtD
Valrubicin—Nausea—Losartan—type 2 diabetes mellitus	0.000917	0.00101	CcSEcCtD
Valrubicin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—type 2 diabetes mellitus	0.000908	0.0221	CbGpPWpGaD
Valrubicin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000906	0.000998	CcSEcCtD
Valrubicin—Dizziness—Ramipril—type 2 diabetes mellitus	0.000876	0.000964	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—STAR—type 2 diabetes mellitus	0.000861	0.021	CbGpPWpGaD
Valrubicin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000842	0.000927	CcSEcCtD
Valrubicin—Rash—Ramipril—type 2 diabetes mellitus	0.000835	0.000919	CcSEcCtD
Valrubicin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000834	0.000919	CcSEcCtD
Valrubicin—Headache—Ramipril—type 2 diabetes mellitus	0.00083	0.000914	CcSEcCtD
Valrubicin—Nausea—Ramipril—type 2 diabetes mellitus	0.000787	0.000866	CcSEcCtD
Valrubicin—TOP2A—Circadian rythm related genes—HNF1B—type 2 diabetes mellitus	0.000702	0.0171	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—PSMD6—type 2 diabetes mellitus	0.000639	0.0156	CbGpPWpGaD
Valrubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—type 2 diabetes mellitus	0.000621	0.0151	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PRKAA1—type 2 diabetes mellitus	0.000602	0.0147	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—MTNR1B—type 2 diabetes mellitus	0.000597	0.0145	CbGpPWpGaD
Valrubicin—TOP2A—Gastric Cancer Network 2—EGFR—type 2 diabetes mellitus	0.000575	0.014	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	0.000554	0.0135	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	0.000537	0.0131	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—CPT1A—type 2 diabetes mellitus	0.000532	0.013	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—NAMPT—type 2 diabetes mellitus	0.000522	0.0127	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CCND2—type 2 diabetes mellitus	0.000521	0.0127	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—F7—type 2 diabetes mellitus	0.000494	0.0121	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—type 2 diabetes mellitus	0.000467	0.0114	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—SREBF1—type 2 diabetes mellitus	0.000465	0.0113	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—GHRL—type 2 diabetes mellitus	0.000441	0.0107	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	0.000438	0.0107	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—ADIPOQ—type 2 diabetes mellitus	0.000427	0.0104	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—PPP2CA—type 2 diabetes mellitus	0.000408	0.00994	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	0.000384	0.00936	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	0.000354	0.00863	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.00035	0.00853	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PPARGC1A—type 2 diabetes mellitus	0.000347	0.00847	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—AVP—type 2 diabetes mellitus	0.000343	0.00835	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—SIRT1—type 2 diabetes mellitus	0.000336	0.00819	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	0.000301	0.00733	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—FAS—type 2 diabetes mellitus	0.000289	0.00704	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PPARA—type 2 diabetes mellitus	0.000279	0.00681	CbGpPWpGaD
Valrubicin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—type 2 diabetes mellitus	0.000267	0.00651	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—LEP—type 2 diabetes mellitus	0.000265	0.00646	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—NOS2—type 2 diabetes mellitus	0.000247	0.00602	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—PSMD6—type 2 diabetes mellitus	0.000234	0.00571	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000232	0.00566	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—PPARG—type 2 diabetes mellitus	0.000231	0.00563	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000228	0.00556	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—PSMD6—type 2 diabetes mellitus	0.00021	0.00511	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—SERPINE1—type 2 diabetes mellitus	0.000208	0.00507	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000199	0.00486	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CCND2—type 2 diabetes mellitus	0.000191	0.00466	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000189	0.00461	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000176	0.00428	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN2B—type 2 diabetes mellitus	0.000171	0.00418	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CCND2—type 2 diabetes mellitus	0.000171	0.00416	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000164	0.004	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDKN2B—type 2 diabetes mellitus	0.000153	0.00373	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000153	0.00373	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—PPP2CA—type 2 diabetes mellitus	0.00015	0.00365	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.000149	0.00363	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000137	0.00333	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000134	0.00327	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—PPP2CA—type 2 diabetes mellitus	0.000134	0.00326	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000128	0.00311	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	0.000126	0.00307	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—PRKCB—type 2 diabetes mellitus	0.000113	0.00275	CbGpPWpGaD
Valrubicin—TOP2A—Circadian rythm related genes—IL6—type 2 diabetes mellitus	9.9e-05	0.00241	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	9.8e-05	0.00239	CbGpPWpGaD
Valrubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	9.51e-05	0.00232	CbGpPWpGaD
Valrubicin—TOP2A—Cell Cycle—CDKN2A—type 2 diabetes mellitus	8.76e-05	0.00214	CbGpPWpGaD
